Business · 26/08/2021Updated: 10/17/2026 · 1 min read

FDA Renews Nonprescription Drugs Advisory Committee for 2 Additional Years

The FDA has renewed the Nonprescription Drugs Advisory Committee for an additional 2 years, with the new charter set to expire on August 27, 2023, following a determination by the Commissioner of Food and Drugs that it is in the public interest to do so.